SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (603)11/12/2003 10:59:20 AM
From: tuck  Read Replies (2) of 897
 
Yeah, but their melanoma results looked pretty good. Whatever, BSCP maintains its position with more confidence as a result.

I can't believe VXGN is even flirting with $9. I tried to sell some calls a while ago with the stock at $9.40, but missed. They've had some bioterror wins, but their HIV vaccine is officially dead today. Should be a $5 stock, IMO.

So have you sold your ALXN?

PS Congrats again to Ralf on his VRTX call. BSCP would be rich if it had just put in a market order when he made it.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News